RxDoctor Payments Data

Kristine Rednour, PA

Physician Assistant · Apollo Beach, FLNPI 1497767917

Payments from drug & device makers

$6,892in general payments, 2019–2025

Across 392 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$847
  • Pfizer$537
  • Bayer$452
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$396
  • Novo Nordisk$362
  • plus $3K from 45 others

What the payments were for

  • Food & beverage$6,892100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,892 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$38,118
Medicare patients
249
Services billed
523

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban70$70,973
OzempicSemaglutide53$56,784
MounjaroTirzepatide16$30,447
JanuviaSitagliptin Phosphate31$29,213
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$28,275
RybelsusSemaglutide12$24,947
JardianceEmpagliflozin19$21,736
ProliaDenosumab11$19,481
XareltoRivaroxaban15$17,376
FarxigaDapagliflozin Propanediol13$12,265
LinzessLinaclotide14$11,072
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$10,246
SymbicortBudesonide/Formoterol Fumarate15$6,263
SynthroidLevothyroxine Sodium54$3,956
Albuterol Sulfate HfaAlbuterol Sulfate105$3,861

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$362$81,73265 claims
PfizerEliquis$537$70,97370 claims
Lilly USA, LLCMounjaro$847$30,44716 claims
MerckJanuvia$57$29,21331 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$258$28,77445 claims
GSKTrelegy Ellipta$139$28,27538 claims
Boehringer IngelheimJardiance$215$21,73619 claims
AmgenProlia$123$19,48111 claims
Johnson & JohnsonXarelto$53$17,37615 claims
AbbVieLinzess, Synthroid$1,130$15,02768 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Apollo Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →